Evaluating the impact of Laws Regulating Illicit Drugs on Health and Society serves as an informative reference for social science researchers and policymakers on the science behind drug regulation.The book presents contributions from many leading researchers in drug law and policy evaluation. The 12 chapters highlight scientific evidence from a diverse range of international projects on evaluation of different illicit drug laws. Each contribution takes policies into account while also using methodological tools and relevant data sets.For a priori evaluation, the modern leximetric approach is applied to compare different drug laws. For posterior evaluation the analysis of social and health outcomes, using standard and new indicators are presented, discussed and applied. Next, the book covers the use of drug market estimation methods in policy research. Specific new indicators allowing the evaluation of interventions such as harm reduction and prevention are presented and analysed using international research data. The book concludes with a summary of the links of illegal drug market gains with corruption, and its consequences.Evaluating the impact of Laws Regulating Illicit Drugs on Health and Society gives readers a unique, evidence-based perspective on the relationship between drugs, laws, policy and socioeconomic conditions. Key FeaturesFeatures 12 contributions from international experts on drug legislation and social scienceDemonstrates evidence-based evaluation of drug laws and policiesHighlights Leximetric and forecast methods applied to illicit drug laws with examplesHighlights the use of standard and new socioeconomic indicators to evaluate drug laws and policiesInforms readers about different policy approaches to drug regulation and their consequencesSummarizes the links of illegal drug markets with corruption Provides detailed ; references for further reading.
| Title |
Evaluating the Impact of Laws Regulating Illicit Drugs on Health and Society. |
|---|---|
| Edition |
1st ed. |
| Publisher |
Sharjah : Bentham Science Publishers |
| Creation Date |
2023 |
| Content |
Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- The First Application of Leximetric Analysis on the Drug Law in Italy -- Francesca De Marinis1,* -- INTRODUCTION -- HOW THE METHODOLOGY WORKS -- THE OBJECT OF THE STUDY -- IDENTIFICATION OF THE VARIABLES AND ELABORATION OF A SCALE -- COMPARISON BETWEEN LAWS OVER TIME: LEXIMETRICS SCORES -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- A Review of the NERA Model Applied to the Recreational Use of Marijuana in the State of Washington -- Yusra Bibi Ruhomally1 and Muhammad Zaid Dauhoo1,* -- INTRODUCTION -- THE NERA MODEL -- MODELLING THE DYNAMICS OF RECREATIONAL MARIJUANA USE IN THE CONTEXT OF LEGALIZATION, IN COLORADO AND WASHINGTON FOR THE PERIOD 2002-2015 -- THE NERA MODEL USING DATA AVAILABLE IN -- ESTIMATION OF PARAMETERS USING GENETIC ALGORITHM -- CONCLUDING REMARKS -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGMENTS -- REFERENCES -- HAT Wars: The Political History of Heroin- Assisted Treatment -- Christopher Hallam1,* -- INTRODUCTION: THE CONTROVERSY OVER HEROIN-ASSISTED TREATMENT -- HISTORICAL CONTEXT -- THE EMERGENCE OF ADDICTION -- UNITED STATES DRUG POLICY AND THE GLOBAL REGIME -- BRITAIN AND THE ROLLESTON COMMITTEE -- THE SWISS EXPERIMENT AND THE BIRTH OF CONTEMPORARY HAT -- OTHER EARLY TRIALS: DUTCH HAT -- HAT IN GERMANY -- CONCLUSIVE REMARKS: HOW GOES THE HAT WAR? -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- The Effectiveness and Efficacy of Prescribed Diacetylmorphine (Heroin) in Reducing Drug-related Harms -- Jeanette Bowles1,2,*, Nazlee Maghsoudi MGA1,3, Samantha Young4,5,6, Sarah Griffiths4 and Gillian Kolla7 -- INTRODUCTION. WHAT IS HEROIN-ASSISTED TREATMENT? -- SETTINGS OF DISPENSATION -- BODY OF EVIDENCE -- Evidence of Impact on Risk Behaviours and Infectious Disease Implications -- Evidence of Impact on Employment, Income, Education, and Well-being -- Evidence of Cost-effectiveness and Public Order -- Evidence of the Side Effects and Consequences of Discontinuation for Heroin-assisted Treatment -- HEROIN-ASSISTED TREATMENT GLOBALLY -- ITERATIONS OF HEROIN-ASSISTED TREATMENT -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- The Hospitalization Risk Profile of Opioids Users -- Valerio Manno1, Alice Maraschini1, Susanna Conti2 and Giada Minelli1,* -- INTRODUCTION -- METHODS -- Data Source -- Case Definition -- Statistical Analysis -- Comorbidities -- TRENDS OF HOSPITALIZATION IN OPIOID USERS BY AGE AND GENDER -- DEMOGRAPHIC CHARACTERISTICS OF PATIENTS HOSPITALIZED WITH DIAGNOSES RELATED TO OPIOIDS USE -- COMORBIDITY ANALYSIS -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Epidemiological Models to Assess Heroin Epidemic Waves and Treatment Outcomes -- Carla Rossi1,* -- INTRODUCTION -- SECOND HEROIN/OPIOIDS EPIDEMIC WAVE -- The Second Wave of Heroin Epidemic in Italy -- Estimate of The Heroin Market Size in Italy Using Two Different Methods -- Comparison of the Trend Of Overdose Deaths in Italy and in Switzerland in the 1995-2016 Time Period -- THE BASICS OF DYNAMIC MODELS FOR THE SPREAD OF INFECTIOUS DISEASES -- S-I-S Model Equations for Closed Populations -- S-I-R model Equations for Closed Populations -- THE MOVER-STAYER DYNAMIC MODEL OF HEROIN/OPIOIDS EPIDEMIC -- USING THE MODEL TO EVALUATE DRUG POLICY INTERVENTIONS AS HEROIN-ASSISTED TREATMENT (HAT) -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION. CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Development of New Indicators for Assessing the Level and Consequences of Drug Use: Applications and Comparisons -- Francesco Fabi1 and Carla Rossi1,* -- INTRODUCTION -- METHODS -- DATA ANALYSES AND RESULTS -- Application to 2012 PDU Survey -- Application to Drug Use Data of Adolescents in 38 European Countries -- Application to ESPAD-Italy Data of High School Students in the Years 2012-2016 -- Measuring the Consequences of Poly-Drug use Among Adolescents: School Dropouts -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Evaluating Treatment Outcomes from Drug Policies and Practices -- Catherine Maria Comiskey1,*, Elizabeth Mary McCarthy1, Zoe Swithenbank2 and Gordon Hay2 -- INTRODUCTION AND THE NEED TO EVALUATE TREATMENT POLICIES -- METHODOLOGICAL CONSIDERATION WHEN EVALUATING TREATMENT OUTCOMES -- Study Design -- Defining Measurable Treatment Goals at the Population And Individual Level -- Defining Treatment Modalities, Settings, and Inclusion Criteria -- Alternatives to Traditional Treatment Outcome Studies -- MEASURING OUTCOMES: CASE STUDIES FROM PRACTICE -- ROSIE (Research Outcome Study in Ireland Evaluating Drug Treatment Effectiveness) -- DTORS -- SURE (Substance Use Recovery Evaluator Study) -- LiR (Life in Recovery) -- NDTMS -- Case Study: Drugs Data Warehouse -- ASSESSING TREATMENT POLICY IMPLEMENTATION -- CONCLUDING REMARKS, THE FUTURE OF TREATMENT POLICY EVALUATION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Using Supply Indicators in the Evaluation of Drug Supply Reduction - Challenges and Opportunities -- Nicola Singleton1, Andrew Cunningham2, Teodora Groshkova2,*, Luis Royuela2, Roumen Sedefov2 and Paul Griffiths2 -- INTRODUCTION. A CONCEPTUAL FRAMEWORK FOR DRUG SUPPLY INDICATORS -- USING SUPPLY INDICATORS IN DRUG POLICY MONITORING AND EVALUATION -- WHAT ARE THE MAIN CHALLENGES TO THE INTERPRETATION OF DRUG SUPPLY INDICATORS? -- Using Administrative Data -- Differing Recording and Reporting Practices -- Timeliness and Robustness Concerns -- Discontinuities in Data Provision -- A STRATEGY FOR IMPROVING SUPPLY INDICATOR COLLECTION AND ANALYSIS -- Improving the Existing Data Collections -- Extending the Range and Scope of the Data Collected -- Improving Analysis -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Estimating the Size of the Drug Market - A Critical Review of Approaches Used -- Robin Udrisard1,*, Calum Griffiths2, Pierre Esseiva3, Frank Zobel1, Teodora Groshkova2 and Andre Noor2 -- INTRODUCTION- ESTIMATING THE SIZE OF THE DRUG MARKET: A CHALLENGING PROPOSITION -- APPROACHES TO ESTIMATING THE DRUG MARKET -- Demand-side Approaches -- Estimating Drug Prevalence -- Problems Associated With Reporting of Drug Behaviours -- Approaches to Non-Response and Underreporting -- Assigning Quantities -- Top-Down Supply Side Approaches -- New and Innovative Approaches that may Inform MSE -- CONCLUSIONS -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Estimating the Costs of the Criminal Justice System -- Luca Di Censi1 and Francesco Fabi2,* -- INTRODUCTION: OBJECTIVE AND METHODOLOGY OF COST ANALYSIS -- GENERAL OVERVIEW: ECONOMIC AND CRIMINAL JUSTICE DATA -- Estimated Cost for the Justice Sector, 2010 and 2018 -- Brief Description of the Prison Situation in the Four Countries, and Estimated Costs -- Italy -- Poland5 -- Portugal -- Spain7 -- Estimated Cost for Prisoners, 2010 and 2018. CONCLUSION ON THE COSTS OF THE CRIMINAL JUSTICE SYSTEM IN ITALY, POLAND, PORTUGAL AND SPAIN -- DATA SOURCES -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Drug Crime and Corruption -- Carla Rossi1,* -- INTRODUCTION -- EARN MONEY IN ILLEGAL DRUG TRADE AND INVEST IT IN CORRUPTION: CONSEQUENCES -- CONCLUDING REMARKS -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Subject Index -- Back Cover. |
| Extent |
1 online resource (225 pages) |
| Language |
English |
| Copyright Date |
©2023. |
| National Library system number |
997012951978505171 |
Have more information? Found a mistake?
